<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <title>Funding</title>
 <p>This research was funded by the European Regional Development Funds (FEDER RE0022527 ZEBRATOX, EU-Région Réunion-French State national counterpart), the University of La Réunion, and the Institut National de la Santé et de la Recherche Médicale. Bryan Veeren is a recipient of a fellowship from the Région Réunion.</p>
</notes>
